Mira Pharmaceuticals
By A Mystery Man Writer
Description
Mira Pharmaceuticals | 1,002 followers on LinkedIn. Developing the next-generation FDA-approved novel synthetic THC analog | MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic pain without impurities or the adverse side effects of cannabis plant extracts.
Tekmira to Present at the 16th Annual BIO CEO & Investor Conference
MIRA Pharmaceuticals, Inc. : Shareholders Board Members Managers and Company Profile, US60458C1045
PR News Accounts in Transit: Axia PR Picks Up Aeroseal - Tue., Sep. 12, 2023
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, Quote & News - Stock Analysis
Mira Pharmaceuticals Files For $16m IPO - Business of Cannabis
Candaur Pharmaceuticals Pvt Ltd in Mira Road East,Mumbai - Best Pharmaceutical Distributors in Mumbai - Justdial
MIRA Pharmaceuticals Set to Disrupt Cannabis and Pharma Markets with Nasdaq
MIRA, MIRALOGX sign agreement for depression therapy
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, Quote & News - Stock Analysis
Maryland Inno - Baltimore's MIRA Pharmaceuticals raises $8.9 million from IPO
Mira Pharmaceuticals is Focued on Treating Anxiety and Cognitive Decline! (NASDAQ:MIRA)
Mira Pharmaceuticals DRS/A Draft registration statement (amended)
from
per adult (price varies by group size)
